Background: Bronchoscopy is a safe and minimally invasive diagnostic tool, but no studies have reported prospectively on sedation and outcomes in patients with objectively defined obesity. Objectives: The purpose of the study is to determine if obese patients require more sedation or had more procedural complications during bronchoscopy under moderate sedation than non-obese patients. Methods: We evaluated complications and sedation requirements in non-obese versus obese patients, defined by multiple criteria including body mass index (BMI), neck circumference, abdominal height, and Mallampati scores. Results: Data were collected prospectively in 258 patients undergoing bronchoscopy under moderate sedation. By varying criteria, there were the following proportions of obese patients: 30% by BMI >30, 39% by neck circumference >40 cm, and 35% by abdominal height >22 cm in males and >20 cm in females. Sedative and analgesic dosing was not clinically significantly higher in obese patients than in non-obese patients. There was no difference in complications or procedural success based on obesity criteria. Hemoglobin oxygen desaturations occurred more often during bronchoscopy in patients with increasing Mallampati scores (p = 0.04), but this had no effect on bronchoscopy time or successful completion of the procedure. A subset of patients with previous polysomnogram-proven obstructive sleep apnea were more likely to have earlier termination of their procedure (15.8%) than patients with no diagnosed sleep apnea (2.3%; p = 0.002). Conclusion: In this prospective assessment of patients with obesity, we found neither clinically significant differences in sedation needs nor increases in complications in obese versus non-obese patients using a variety of indices of obesity.

Keywords:
Bronchoscopy, Complications, Sedation, Obesity
1.
World Health Organization: Obesity and overweight. http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed March 29, 2016).
2.
Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
3.
Flegal KM, Carroll MD, Ogden CL, Curtin LR: Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-241.
4.
WHO Global Infobase. https://apps.who.int/infobase/Comparisons.aspx (accessed May 1, 2012).
5.
Jin F, Mu D, Chu D, Fu E, Xie Y, Liu T: Severe complications of bronchoscopy. Respiration 2008;76:429-433.
6.
Suratt PM, Smiddy JF, Gruber B: Deaths and complications associated with fiberoptic bronchoscopy. Chest 1976;69:747-751.
7.
World Health Organization: Global Database on Body Mass Index. www.who.int/bmi/index.jsp?introPage=intro_3.html (accessed May 1, 2012).
8.
Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, Khajehdehi A, Shapiro CM: STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology 2008;108:812-821.
9.
Sweitzer BJ, Smetana GW: Identification and evaluation of the patient with lung disease. Med Clin North Am 2009;93:1017-1030.
10.
Katz I, Stradling J, Slutsky AS, Zamel N, Hoffstein V: Do patients with obstructive sleep apnea have thick necks? Am Rev Respir Dis 1990;141(pt 1):1228-1231.
11.
Risérus U, de Faire U, Berglund L, Hellénius ML: Sagittal abdominal diameter as a screening tool in clinical research: cutoffs for cardiometabolic risk. J Obes 2010;2010:757939.
12.
Mallampati SR, Gatt SP, Gugino LD, Desai SP, Waraksa B, Freiberger D, Liu PL: A clinical sign to predict difficult endotracheal intubation: a prospective study. Can Anaesth Soc J 1985;32:429-434.
13.
Maltais F, Laberge F, Laviolette M: A randomized, double-blind, placebo-controlled study of lorazepam as premedication for bronchoscopy. Chest 1996;109:1195-1198.
14.
Putinati S, Ballerin L, Corbetta L, Trevisani L, Potena A: Patient satisfaction with conscious sedation for bronchoscopy. Chest 1999;115:1437-1440.
15.
Khan I, Haponik E, Chatterjee A, Chin RJ, Conforti J: Is sedation necessary for successful completion of flexible bronchoscopy? Clin Pulm Med 2010;17:244-247.
16.
Passannante AN, Rock P: Anesthetic management of patients with obesity and sleep apnea. Anesthesiol Clin North America 2005;23:479-491, vii.
17.
Blouin RA, Warren GW: Pharmacokinetic considerations in obesity. J Pharm Sci 1999;88:1-7.
18.
Shibutani K, Inchiosa MA, Sawada K, Bairamian M: Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight (‘pharmacokinetic mass'). Anesthesiology 2004;101:603-613.
19.
Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, et al: Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) 2008;32:959-966.
20.
Iribarren C, Darbinian JA, Lo JC, Fireman BH, Go AS: Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population. Am J Epidemiol 2006;164:1150-1159.
21.
Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Trevisan M, et al: Pulmonary function and abdominal adiposity in the general population. Chest 2006;129:853-862.
22.
Empana JP, Ducimetiere P, Charles MA, Jouven X: Sagittal abdominal diameter and risk of sudden death in asymptomatic middle-aged men: the Paris Prospective Study I. Circulation 2004;110:2781-2785.
23.
Cillo JE Jr, Finn R: Hemodynamics and oxygen saturation during intravenous sedation for office-based laser-assisted uvuloplasty. J Oral Maxillofac Surg 2005;63:752-755.
24.
Pue CA, Pacht ER: Complications of fiberoptic bronchoscopy at a university hospital. Chest 1995;107:430-432.
25.
Geraci G, Pisello F, Sciumè C, Li Volsi F, Romeo M, Modica G: Complication of flexible fiberoptic bronchoscopy. Literature review (in Italian). Ann Ital Chir 2007;78:183-192.
26.
Pereira W Jr, Kovnat DM, Snider GL: A prospective cooperative study of complications following flexible fiberoptic bronchoscopy. Chest 1978;73:813-816.
27.
Dreisin RB, Albert RK, Talley PA, Kryger MH, Scoggin CH, Zwillich CW: Flexible fiberoptic bronchoscopy in the teaching hospital. Yield and complications. Chest 1978;74:144-149.
28.
Dang D, Robinson PC, Winnicki S, Jersmann HP: The safety of flexible fibre-optic bronchoscopy and proceduralist-administered sedation: a tertiary referral centre experience. Intern Med J 2012;42:300-305.
29.
Kaparianos A, Argyropoulou E, Sampsonas F, Zania A, Efremidis G, Tsiamita M, Spiropoulos K: Indications, results and complications of flexible fiberoptic bronchoscopy: a 5-year experience in a referral population in Greece. Eur Rev Med Pharmacol Sci 2008;12:355-363.
30.
Chhajed PN, Aboyoun C, Chhajed TP, Malouf MA, Harrison GA, Tamm M, Leuppi JD, Glanville AR: Sedative drug requirements during bronchoscopy are higher in cystic fibrosis after lung transplantation. Transplantation 2005;80:1081-1085.
31.
Eikermann M, Garzon-Serrano J, Kwo J, Grosse-Sundrup M, Schmidt U, Bigatello L: Do patients with obstructive sleep apnea have an increased risk of desaturation during induction of anesthesia for weight loss surgery? Open Resp Med J 2010;4:58-62.
32.
Meghjee SP, Marshall M, Redfern EJ, McGivern DV: Influence of patient posture on oxygen saturation during fibre-optic bronchoscopy. Respir Med 2001;95:5-8.
33.
Chhajed PN, Wallner J, Stolz D, Baty F, Strobel W, Brutsche MH, Tamm M: Sedative drug requirements during flexible bronchoscopy. Respiration 2005;72:617-621.
34.
Moore WC, Evans MD, Bleecker ER, Busse WW, Calhoun WJ, Castro M, et al; National Heart, Lung, and Blood Institute's Severe Asthma Research Group: Safety of investigative bronchoscopy in the Severe Asthma Research Program. J Allergy Clin Immunol 2011;128:328-336.e3.
35.
Bellinger CR, Khan I, Chatterjee AB, Haponik E: Bronchoscopy safety in patients with chronic obstructive lung disease. J Bronchol Interven Pulm, accepted for publication.
36.
Credle WF Jr, Smiddy JF, Elliott RC: Complications of fiberoptic bronchoscopy. Am Rev Respir Dis 1974;109:67-72.
37.
Dhariwal A, Plevris JN, Lo NT, et al: Age, anemia, and obesity-associated oxygen desaturation during upper gastrointestinal endoscopy. Gastrointest Endosc 1992;38:684-688.
38.
Iwao T, Toyonaga A, Harada H, Harada K, Ban S, Ikegami M, Tanikawa K: Arterial oxygen desaturation during non-sedated diagnostic upper gastrointestinal endoscopy. Gastrointest Endosc 1994;40:227-280.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.